The cancer cell's "power plants" as promising therapeutic targets: An overview

Journal of Bioenergetics and Biomembranes

Volumn 39, Issue 1, 2007, Pages 1-12

  Pedersen, Peter L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 bromopyruvate; 3 BrPA; Anti cancer agents; Apoptosis; Bioenergetics; Cancer; Cancer therapy; Cell death; Cytochrome c; Energy metabolism; Glycolysis; Mitochondria; Necrosis; Power plants; Warburg; Warburg effect

Indexed keywords

1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE; IMATINIB; MITOCHONDRIAL DNA; PHOTOFRIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOENERGY; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CLINICAL RESEARCH; GLYCOLYSIS; HUMAN; MITOCHONDRIAL DNA DEPLETION; NONHUMAN; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL DESTRUCTION;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL RESPIRATION; CYTOCHROME C GROUP; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MITOCHONDRIA; NECROSIS; NEOPLASMS; PYRUVATES;

RODENTIA;

EID: 34249945104     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-007-9070-5     Document Type: Review

References (99)

1. Aisenberg AC (1961) The glycolysis and respiration of tumors. Academic Press, New York and London Part II: The Oxidative Metabolism of Tumors, pp 156-157
2. Allison PD (1995) In: Survival analysis using SAS, A practical guide, Chapter 3, SAS Publishing, Cary, North Carolina, pp 30-32
3. Andre N, Rome A, Carre M (2006) Archives de Pediatrie 13:69-75
4. Arora KK, Pedersen PL (1988) J Biol Chem 263:17422-17428
5. Arunkumar A, Vijayababu MR, Gunadharini N, Krishnamoorthy G, Arunakaran J (2006) Cancer Lett. Epub ahead of print
6. Athanasiou A, Smith PA, Vakilpour S, Kumaran NM, Turner AE, Bagiokou D, Layfield R, Ray DE, Westwell AD, Alexander SP, Kendall DA, Lobo DN, Watson SA, Lophatanon A, Muir KA, Guo DA, Bates TE (2007) Biochem Biophys Res Commun 354:50-55
7. Badros A, Goloubeva O, Fenton R, Rapoport AP, Akpek G, Harris C, Ruehle K, Westphal S, Meisenberg B (2006) Clin Lymphoma Myeloma 7:210-216
8. Barna G, Sebestyen A, Weischede S, Petak I, Mihalik R, Formelli F, Kopper L (2005) Anticancer Res 25:4179-4185
9. Bleday R, Weiss MJ, Salem RR, Wilson RE, Chen LB, Steele G Jr (1986) Arch Surg 121:1272-1275
10. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED (2007) Cancer Cell 11:37-51
11. Bouchier-Hayes L, Lartigue L, Newmeyer DD (2005) J Clin Invest 115:2640-2647
12. Britten CD, Rowinsky EK, Baker SD, Weiss GR, Smith L, Stephenson J, Rothenberg M, Smetzer L, Cramer J, Collins W, VonHoff DD, Eckhardt SG (2000) Clin Cancer Res 6:42-49
13. Bustamante E, Pedersen PL (1977) Proc Natl Acad Sci (USA) 74:3735-3739
14. Campas C, Cosialls AM, Barragan M, Iglesias-Serret D, Santidrian AF, Coll-Mulet L, de Frias M, Domingo A, Pons G, Gil J (2006) Exp Hematol 34:1663-1669
15. Carter BZ, Mak DH, Schober WD, McQueen T, Harris D, Estrov Z, Evans RL, Andreeff M (2006) Blood 108:630-637
16. Cereghetti GM, Scorrano L (2006) Oncogene 25:4717-4724
17. Chen BJ (2001) Leuk Lymphoma 42:253-265
18. Chen J, Ramos J, Sirisawad M, Miller R, Naumovski L (2005) Apoptosis 10:1131-1142
19. Chen LB (1989) Methods Cell Biol 29:103-123
20. Cherry SR (2006) J Nuc Med 47:1735-1745
21. Chitambar CR, Wereley JP, Matsuyama SM (2006) Cancer Ther 5:2834-2843
22. Dancy J, Sausville EA (2003) Nat Rev Drug Discov 2:296-313
23. Del Gaizo Moore V, Brown JR, Certo M, Love TM, Novina CD, Letai A (2007) J Clin Invest 117:112-121
24. Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F (2003) Drugs Today (Barc) 39:157-174
25. Don AS, Hogg PJ (2004) Trends Mol Med 10:372-378
26. Efferth T (2006) Curr Drug Targets 7:407-421
27. Eggermont AM (2006) J Clin Oncol 24:4673-4674
28. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA (2005) Int J Cancer 117:409-417
29. Elshimali YI, Grody WW (2006) Diagn Mol Pathol 15:187-194
30. Engel M, Mazurek S, Eingenbrodt E, Welter CJ (2004) J Biol Chem 279:35803-35812
31. Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML (2006) Mol Pharm 70:2108-2115
32. Farber S (1950) Am J Dis Child 79:961-962
33. Fischer OM, Streit S, Hart S, Ullrich A (2003) Curr Opin Chem Biol 7:490-495
34. Fleming A (1929) Br J Exp Pathol 10:226-236
35. Foubister V (2002) DDT 7:934-935
36. Frankel SR (2003) Semin Oncol 30:300-3004
37. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, Schneider-Stock R (2004) Int J Oncol 25:858-866
38. Galluzzi L, Larochette N, Zamzami N, Kroemer G (2006) Oncogene 25:4812-4830
39. Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL (2002) Cancer Res 62:3903-3913
40. Goodsell DS (2004) The Oncologist 9:226-227
41. Greville G (1969) Curr Top Bioenerg 3:1-78
42. Hosler JP, Ferguson-Miller S, Mills DA (2006) Annu Rev Biochem 75:165-187
43. Issat T, Jakobisiak M, Golab J (2006) Oncol Rep 16: 1273-1276
44. Jiang X, Wang X (2004) Annu Rev Biochem 73:87-106
45. Johnson JH, Belt JA, Dubinsky WP, Zimniak A, Racker E(1980) Biochemistry 19:3836-3840
46. Johnson LV, Johnson ML, Chen LB (1980) Proc Natl Acad Sci (USA) 77:990-994
47. Kerkela R, Grazette L, Yacobi R, Iliescu C, Pattern R, Beahm C, Walters G, Shevtsov S, Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, A Van Hatten R, Alroy J, Durand J-B, Force T (2006) Nat Med 12:908-916
48. Kerr JF, Wyllie AH, Currie AR (1972) Br J Cancer 26:239-257
49. Ko JK, Leung WC, Ho WK, Chiu P (2006) Eur J Pharmacol [Epub ahead of print]
50. Ko YH, Pedersen PL, Geschwind (2001) Cancer Lett 173:83-91
51. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL (2004) Biochem Biophys Res Commun 324:269-275
52. Koya K, Li Y, Wang H, Ukai T, Tatsukta N, Kawakami M, Shishido, Chen LB (1996) Cancer Res 56:538-543
53. LeBras M, Borgne-Sanchez A, Touat Z, El Dein OS, Deniaud A, Maillier E, Lecellier G, Rebouilat D, Lemaire C, Kroemer G, Jacotot E, Brenner C (2006) Cancer Res 66:9143-9152
54. Li YC, Fung KP, Kwok TT, Lee CY, Suen YK, Kong SK (2002) Life Sci 71:2729-2740
55. Malhi H, Gores GJ, Lemasters JJ (2006) Hepatology 43:S31-S44
56. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) Science 298:1912-1934
57. Marcinkowska A, Malarska A, Saczko J, Chwilkowska A, Wysocka T, Drag-Zalesinska M, Wysocka T, Banas T (2001) Folia Histochem Cytobiol 39(Suppl 2):177-178
58. Mathupala SP, Ko YH, Pedersen PL (2006) Oncogene 25:4777-4786
59. Mathupala SP, Parajuli P, Sloan AE (2004) Neurosurgery 55:1410-1419
60. McGuire JJ (2003) Curr Pharm Design 9:2593-2613
61. Mitchell P (1961) Nature 191:144-148
62. Nakashima RA, Paggi MG, Pedersen PL (1984) Cancer Res 44:5702-5706
63. Nakashima RA, Managan PS, Colombini M, Pedersen PL (1986) Biochemistry 25:1015-1021
64. Neuzil J, Wang X-F, Dong L-F, Low P, Ralph SJ (2006) FEBS Lett 580:5125-5129
65. Niizuma H, Nakamura Y, Ozaki T, Nakanishi H, Ohira M, Isogai E, Kageyama H, Imaizumi M, Nakagawara A (2006) Oncogene 25:5046-5055
66. Oh KW, Qian T, Brenner DA, Lemaster JJ (2003) Toxicol Sci 73:44-52
67. Palozza P, Serini S, Torsello A, Dinicuolo F, Maggiano N, Ranelletti FO, Wolf FI, Calviello G (2003) Nutr Cancer 47:76-87
68. Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S (2006) Anticancer Res 26(1A):259-265
69. Pastorino JG, Shulga N, Hoek JB (2002) J Biol Chem 277:7610-7618
70. Pedersen PL (1978) Prog Exp Tumor Res 22:190-274
71. Pelicano H, Martin DS, Xu R-H, Huang P (2006) Oncogene 25:4633-4646
72. Perchellet EM, Wang Y, Weber RL, Lou K, Hua DH, Perchellet JP (2004) Anticancer Drugs 15:929-946
73. Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, A Van Hatten R, Alroy J, Durand J-B, Force T (2006) Nat Med 12:908-916
74. Pisano M, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G, Fabbri D, Dettori MA, Delogus G, Ponzoni M, Rozzo C (2007) Mol Cancer 6:8
75. Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF, Li LC, Dahiya R (2007) Biochem Biophys Res Commun 354:852-857
76. Rall TW, Sutherland EW (1958) J Biol Chem 232:1065-1076
77. Richards GM, Mehta MP (2007) Expert Opin Pharmacother 8:351-359
78. Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, Dammacco F, Anderson KC (2006) Curr Pharm Biotechnol 7:441-448
79. Rzeski W, Stepulak A, Szymanski M, Sifringer M, Kaczor J, Wejksza K, Zdzisinka B, Kandefer-Szerszen M (2006) Naunyn Schmiedebergs Arch Pharmol 374:11-20
80. Sancho P, Galeano E, Nieto E, Delgado MD, Garcia-Perez AI (2007) Leukema Research (On Line)
81. Schreiber JR, Balcavage WX, Morris HP, Pedersen PL (1970) Cancer Res 30:2497-2501
82. Shen PF (2004) Front Biosci 9:2663-2670
83. Shields AF (2006) Mol Imaging Biol 8:141-150
84. Spencer TL, Lehninger AL (1976) Biochem J 154:405-414
85. Strebhardt K, Ullrich A (2006) N Eng J Med 355:2481-2482
86. Sun X, Wong JR, Song K, Hu J, Garlid KD, Chen LB (1994) Cancer Res 54:1465-1471
87. Sutherland EW, Rall TW (1958) J Biol Chem 232:1077-1092
88. Tang L, Jin T, Zeng X, Wang JS (2005) J Nutr 135:287-290
89. Wang Y, Perchellet EM, Ward MM, Lou K, Zhao H, Battina SK, Wiredu B, Hua DH, Perchellet JP (2006b) Int J Oncol 28:161-172
90. Wang XS, Yang W, Tao SJ, Li K, Li M, Dong JH, Wang MH (2006a) Yakuqaku Zasshi 126:979-990
91. Warburg O (1930) The metabolism of tumors. Constable, London
92. Weber G (1968) Naturwissenschaften 55:418-429
93. Weber G (2001) Biochem (Mosc) 66(10):1164-1173
94. Weber G, Lea MA (1966) Adv Enzyme Regul 4:115-145
95. Weinhouse S (1972) Cancer Res 32:2007-2016
96. Weiss MJ, Wong JR, Ha CS, Bleday R, Salem RR, Steele GD Jr, Chen LB (1987) Proc Natl Acad Sci 84:5444-5448
97. Weiss MJ, Wong JR, Ha CS, Bleday R, Salem RR, Steele GD Jr (1988) Annu Rev Cell Biol 4:155-181
98. Xu RH, Pelicano H, Zhang H, Giles FJ, Keating MJ, Huang P (2005) Leukemia 19:2153-2158
99. Zhang XD, Deslandes E, Villedieu M, Poulain L, Duval M, Gauduchon P, Schwartz L, Icard P (2006) Anticancer Res 26: 3561-3566